A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness.
about
Tuberculosis and HIV co-infectionHIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentVisualization and quantification of simian immunodeficiency virus-infected cells using non-invasive molecular imaging.Oncostatin M promotes excitotoxicity by inhibiting glutamate uptake in astrocytes: implications in HIV-associated neurotoxicityA growth factor attenuates HIV-1 Tat and morphine induced damage to human neurons: implication in HIV/AIDS-drug abuse casesModeling HIV-1 Induced Neuroinflammation in Mice: Role of Platelets in Mediating Blood-Brain Barrier DysfunctionThe National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment.Human immunodeficiency virus type 1 efficiently binds to human fetal astrocytes and induces neuroinflammatory responses independent of infectionProteomic modeling for HIV-1 infected microglia-astrocyte crosstalk.Protective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challengesHIV-1 Tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells.Depletion of dendritic cells enhances susceptibility to cell-free infection of human T cell leukemia virus type 1 in CD11c-diphtheria toxin receptor transgenic mice.Increase in DNA vaccine efficacy by virosome delivery and co-expression of a cytolytic protein.Induction of SerpinB2 and Th1/Th2 modulation by SerpinB2 during lentiviral infections in vivoLoss of neuronal integrity during progressive HIV-1 infection of humanized mice.Glial TNFα in the spinal cord regulates neuropathic pain induced by HIV gp120 application in ratsAn infectious murine model for studying the systemic effects of opioids on early HIV pathogenesis in the gutNeuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.Rodent models for HIV-associated neurocognitive disorders.Translating the brain transcriptome in neuroAIDS: from non-human primates to humans.Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection?A Mouse Model of Latent Tuberculosis Infection to Study Intervention Strategies to Prevent ReactivationCRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirsMice chronically infected with chimeric HIV resist peripheral and brain superinfection: a model of protective immunity to HIV.Vaccine-induced protection from infection of mice by chimeric human immunodeficiency virus type 1, EcoHIV/NL4-3.STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier.A rat model of human immunodeficiency virus 1 encephalopathy using envelope glycoprotein gp120 expression delivered by SV40 vectors.Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance.The HIV-1 transgenic rat model of neuroHIV.Problems and emerging approaches in HIV/AIDS vaccine development.Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDSTargeting the glutamatergic system for the treatment of HIV-associated neurocognitive disordersGenetic knockouts suggest a critical role for HIV co-receptors in models of HIV gp120-induced brain injuryBattle of animal models.A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice.Murine models for HIV vaccination and challenge.Transmission of chimeric HIV by mating in conventional mice: prevention by pre-exposure antiretroviral therapy and reduced susceptibility during estrus.Encoded novel forms of HSP70 or a cytolytic protein increase DNA vaccine potency.Enhanced human immunodeficiency virus Type 1 expression and neuropathogenesis in knockout mice lacking Type I interferon responses.Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses.
P2860
Q21131403-62750BB4-1543-439F-A054-CE2CCE2F1A05Q26766448-5EC7EB65-990A-4FBD-A999-810156098A4AQ27323244-3345330E-5F13-421E-A1E5-1C45736251C7Q28396730-12172263-0343-4668-8DEC-DB365F7D8C5DQ28477511-B2D51944-0C34-49A8-BBB0-4BB8F6928007Q28550869-4D85D868-E97E-46E0-AF1D-946C177B1A36Q31104394-974F062D-F05C-4640-A6B2-FCA08CF945FCQ33284463-4375742F-8A7A-48AA-B42C-8F7F4527DA8AQ33346280-D215F22E-7708-45B7-BBFF-96C9072BCFB1Q33916635-B4EC432B-203B-4792-91A7-3BC9C0CA9228Q34017780-CC700DAA-6E5E-437C-B3A6-EC7F51FFCF52Q34157297-E30F3CD7-A84B-4722-93F4-9BF4049A49B8Q34511631-245E1B61-62A7-442E-9735-EAAA820A6AEEQ34608495-B9F22924-7C3F-40B9-AB39-1EA158A8170EQ34690832-21A3D73D-33FF-41EF-8E42-872B4F97EF07Q35063688-36C71EC6-3B7B-4D29-BEB3-F486EEB1F565Q35108063-D0531773-B476-45E5-9919-AEBA7BBB3095Q35177355-5E8B9E84-25E5-4841-BC62-82E50D115659Q35803957-2653B590-8CDE-4282-A63C-620EFB319568Q35965789-6D04ABBA-03FE-4B8B-BF2A-B6337CD59990Q35984276-2A64713A-D31D-413A-BB52-8259EAAE70A7Q36070875-DF9106A9-BBAE-41B7-9E80-F62A74A91355Q36250079-DAB354E4-4214-4796-85EE-36407613D90BQ36367066-E8D0B835-B274-4B4F-80A4-01C912AC1F67Q36416594-7422991A-2557-4468-89FA-AD5D62BC2EBCQ36445840-D9AC5EE4-29CF-4A16-AEEE-588BF397E5C3Q36458373-8B13D075-F108-4062-81FB-1FAA3AD66D39Q36492916-E82BAD3A-DFD6-4D8F-9CF0-588C66762D4AQ36578522-E09544A9-6E0A-4EB6-8DB0-768A54D615F9Q36758574-2D947A97-5534-447B-9318-88396D738AFBQ36856162-3DF33E9F-9BA1-4076-9B72-6875F19C6598Q36868552-B8696A3F-22A9-4179-B306-F695126E8335Q36950047-FDD48691-0C9C-4C39-96E3-9770AAD3C5EEQ37015533-855E28D8-5FD8-4EC1-9D01-B0C6843E5767Q37054470-70B40BB7-E2CF-4783-B45D-B3B212E3B6C8Q37077665-7B466F80-4316-4030-AB95-1B953A58E2BEQ37137806-6F9E8F9F-35AD-4D32-9245-420055343287Q37154783-F549BB21-037F-4A44-B815-FD6CC9F3E6F0Q37410928-071BEF80-9E46-43F7-BBF6-3DB2891B956EQ37419985-3618F7F2-896F-4868-BE6B-B7779CF9C2B2
P2860
A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A mouse model for study of sys ...... ponses, and neuroinvasiveness.
@ast
A mouse model for study of sys ...... ponses, and neuroinvasiveness.
@en
type
label
A mouse model for study of sys ...... ponses, and neuroinvasiveness.
@ast
A mouse model for study of sys ...... ponses, and neuroinvasiveness.
@en
prefLabel
A mouse model for study of sys ...... ponses, and neuroinvasiveness.
@ast
A mouse model for study of sys ...... ponses, and neuroinvasiveness.
@en
P2093
P2860
P356
P1476
A mouse model for study of sys ...... ponses, and neuroinvasiveness.
@en
P2093
Andrew I Brooks
David J Volsky
Galina Bentsman
Jadwiga Nitkiewicz
Leroy Sharer
Manisha Saini
Mary Jane Potash
Nicolae Paris
Paula Belem
P2860
P304
P356
10.1073/PNAS.0500649102
P407
P577
2005-02-23T00:00:00Z